BENCHMARK PROFILE
Paramount Peptides
Latest sync: Oct 14, 2026, 12:07 AM. Source coverage currently reflects Consensus data.
Readers looking for a public, product-linked archive of vendor-posted batch documents rather than a generic “COA available on request” claim.
The current review records issuer names on 86 current-batch image relationships. The Accumark documents are independently verified; the Janoshik attributions are not. It also observed many product or variation lookups returning no record, so confirm the document and issuer for the specific lot rather than treating the public lookup as complete catalog coverage.
Included because it is a high-ranked consensus vendor with explicit lot-linked COA positioning and a visible public COA lookup path.
Paramount exposes a public product-and-variation COA lookup, but the current evidence is narrower than the prior Janoshik description implied. Across 158 reviewed product pages, 272 product or variation records were checked: 86 returned certificate pages and the rest returned no record. The reviewed set contains 537 relationships to 537 distinct vendor-hosted COA images.
The public lookup needs no account and can be checked by product or variation. Its results are images served from Paramount’s own site: all 537 reviewed relationships are vendor-hosted COA images. Its 86 current-batch certificate hits name Janoshik and Accumark Labs documents. The Accumark sample codes resolve at Accumark Labs under the Paramount client. The Janoshik names on those images still have no recovered laboratory credential. Lot numbers and analysis dates remain useful document fields, but a searchable vendor result does not by itself establish an issuing laboratory.
This vendor is one of 131 names currently included in our manual curated research-vendor layer.
This is a meaningful public transparency pattern, but the documents are still mostly hosted on the vendor side. That makes it stronger than generic claims and weaker than provider-controlled verification.
- Reward the fact that readers can inspect real files without logging in.
- Pay attention to whether the archive is broad, multi-category, or repeated across many products.
- Keep in mind that vendor-hosted files are different from a live third-party verification portal.
This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.
PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.
Paramount Peptides currently reads as a strong curated case because the public trust layer is both inspectable and fairly broad.
Readers can inspect real public documents, even if the vendor still hosts most of the archive.
The trust layer is structured and inspectable, but still mostly vendor-controlled.
Current review touched 158 products and 537 document/link destinations.
2 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.
Score 7.0 from 10-point benchmark blend.
PB Curated Assessment: Strong. This is our own trust/transparency rubric and is kept separate from the PB score.
Under the formula retired on Aug 28, 2026 this vendor scores 7.57 — the live evidence-first score is 6.83 (-0.74). What changed and why: scoring methodology.
Observed from public domain records and the vendor's own site on Aug 27, 2026. Identity facts are shown for context and do not affect scores.
Holding a certificate for this vendor that is not here? Send it to the archive →
Same third-party review signals shown on the vendor board. Click Trustpilot or Pep Review Pro to open the source profile.
PB score is the number you should read first on this page. It starts with trust evidence, pricing coverage, and third-party review signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available. Reviewed transparency evidence contributes a bounded amount — shown as a trust lift for source-benchmarked vendors, and folded into the base score for PB-evidence vendors.
This vendor’s score is evidence-first: verifiable testing evidence forms the backbone, and outside review sources are a bounded adjustment that can warn far more than it can boost. The terms below sum to the displayed score (small rounding aside). Full formula on the scoring methodology page.
WHAT THIS PAGE IS
- Board-ranked vendor profile with source-linked benchmark inputs
- Includes Finnrick score coverage
- Includes Peptide Critic score coverage
- No Trustpilot profile currently linked
- No Pep Review Pro profile currently linked
CURRENT LIMITS
- Not an original lab test or editorial review
- Source scales and methodologies differ across sites
- Depends on source site freshness and formatting
These are representative public examples from the vendor testing review queue. They show how product pages in the catalog expose public report or verification paths, but they should still be read as examples rather than proof for every current lot.
In other words: the relationship registry above captures the vendor-to-provider link itself, while the examples below show what that link looks like across real product pages.
METHODOLOGY
How to read this benchmark
This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.
A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.
Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.